Science
Mechanism of Action
This ingredient operates via a dual-action pathway: physically, it forms a structured film on the stratum corneum to significantly reduce transepidermal water loss (TEWL); biologically, it acts as a potent tyrosinase inhibitor, suppressing the synthesis of melanin within melanocytes and neutralizing oxidative stress.
Research
Clinical Evidence
High confidence0.01%
Key findings
- 01 In vitro trials demonstrated that 0.01% concentration outperformed arbutin in reducing melanin production while simultaneously inhibiting inflammatory markers.
- 02 Studies on human epidermal melanocytes confirmed peak skin-whitening activity at concentrations as low as 50 μg/mL (0.005%).
- 03 Safety assays at 0.02% (200 μg/mL) confirmed zero cytotoxicity, ensuring high biological compatibility for topical application.
Transparency
Dusting Analysis
Because Anhydrogalactose is highly effective at microscopic levels (0.005%–0.01%), many manufacturers include it as part of a generic 'red algae extract' at concentrations below the bioactive threshold for melanin inhibition, using it purely for label claims rather than functional brightening.
The Formula
Formulation
Stability
Thermolabile; must be processed below 90°C to prevent degradation. Highly sensitive to acidic environments below pH 4.0, where it may convert into 5-hydroxymethylfurfural (5-HMF).
Synergies
- Saccharide Isomerate
- Hyaluronic Acid
- Niacinamide
Conflicts
- Strong Alpha Hydroxy Acids (Low pH)
- Strong oxidizing agents
- High-temperature emulsification
Safety
Safety Profile
The CIR Expert Panel considers this ingredient safe in current cosmetic practices. It is non-irritating and exhibits a high safety profile even in sensitive skin formulations.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An exceptional multi-tasker that provides measurable brightening and hydration at remarkably low concentrations, provided the formulation maintains a stable pH.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources